Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vet accuses RCVS of ‘bunker behaviour’
Mr Wray's comments follow recent concerns from the profession about the ongoing debate surrounding telemedicine and remote prescribing.
Comments follow concerns over telemedicine debate 

Vet Jonathan Wray has accused the RCVS of ‘bunker’ behaviour, as he claims recently published council papers held back information on costings, and did not acknowledge general practitioners.

In a letter to Vet Times and Vet Record, Mr Wray commented on papers from the RCVS Council meeting in May:

‘I note the papers are redacted in two respects, in relation to the costs of the activities discussed and in respect of regulatory matters where advice has been sought by third parties relating to RCVS activities.

‘Secondly, not one mention exists of the members of the RCVS who constitute the lion’s share of the profession and primary source of funding of RCVS - the general practitioners.’

The comments follow recent concerns from the profession about the ongoing debate surrounding telemedicine and remote prescribing. In June, the British Veterinary Association (BVA) wrote to the college raising concerns that the debate on the future of telemedicine was held ‘in committee’ rather than in an open forum.

In response, the RCVS clarified that the session had been held in private to examine confidential legal advice.

During the meeting the council voted unanimously to conduct a wide-ranging review of the supporting guidance on 24-hour emergency cover and the interpretation and application of ‘under veterinary care’. The review will explore what restrictions and safeguards to place on remote prescribing.

The proposed telemedicine trial was postponed for the foreseeable future and the college confirmed its review will be ‘open and inclusive’.

At the RCVS annual meeting on Royal College Day (12 July), the college answered questions submitted in advance by email, as well as taking questions from the floor. However, a group of vets are said to be considering the option of forcing an extraordinary general meeting (EGM) of the council.

MRCVSonline contacted the RCVS for comment. A spokesperson confirmed: ‘We have not yet received any formal request to hold an EGM’.

The college also confirmed: ‘Standards Committee is meeting in September to discuss the timeline for the [telemedicine] review and what it will look like’.

RCVS declined to comment specifically on Mr Wray’s letter in Vet Times and Vet Record.

Become a member or log in to add this story to your CPD history

Regional Representatives nominations sought

News Story 1
 Seven new regional representatives are being sought by the British Veterinary Association (BVA) to speak for vets from those regions and to represent their views to BVA Council.

The opportunities are available in in the North-East, Yorkshire & Humber, East Midlands, West Midlands, London, Wales, and Northern Ireland. Representatives from all sectors of the veterinary profession are urged to apply.

BVA president Daniella Dos Santos, said: "Our regional representatives are integral to that mission and to the activities of Council - contributing to effective horizon scanning on matters of veterinary policy and providing an informed steer to BVA’s Policy Committee.” 

Click here for more...
News Shorts
Livestock Antibody Hub receives funding boost

The Pirbright Institute has received US $5.5 million from the Bill and Melinda Gates Foundation to form a Livestock Antibody Hub aimed at supporting animal and human health. The work will bring together researchers from across the UK utilise research outcomes in livestock disease and immunology.

Dr Doug Brown, chief executive of the British Society for Immunology, commented: “The UK is a world leader in veterinary immunology research, and this transformative investment from the Bill & Melinda Gates Foundation will drive the next chapter of innovation in developing new treatments and prevention options against livestock diseases".